Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer

NCT00595088 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
47
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Anchiano Therapeutics Israel Ltd.